A Randomised Controlled Trial to Investigate the Effects of a Structured Self-management Education Programme for People With Metabolic Syndrome
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 82
- 试验地点
- 2
- 主要终点
- The proportion of people in the intervention and control groups with prevalent metabolic syndrome according to the IDF criteria.
研究概览
简要总结
The aim of our study is to see if people with metabolic syndrome who attend a group education programme based on lifestyle changes (dietary and increased physical activity) can lessen their risk of having diabetes, heart disease and strokes in the future.
详细描述
People who have a combination of risk factors termed metabolic syndrome are at increased risk of developing diabetes, heart disease and strokes. Metabolic syndrome is a major public health concern requiring urgent action because 25% of the adult UK population fulfil the criteria, and this will increase as people continue to be less active and levels of overweight and obesity rise.
The aim of our study is to see if people with metabolic syndrome who attend a structured group education programme based on lifestyle changes (dietary and increased physical activity) can lessen their risk of having diabetes and cardiovascular disease in the future. Overall, we hope to show that this type of education reduces the number of people who have metabolic syndrome.
Subjects recruited with metabolic syndrome will be randomised to intervention or control arms. The intervention arm will receive group education and the control group will receive routine care.
The results will inform primary prevention strategies in people from varied ethnic backgrounds who are at high risk of developing type-2 diabetes and cardiovascular disease.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 40 Years 至 74 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Aged 40 - 74 years inclusive
- •Registered with a general practice in Leicester City or Leicester County Primary Care Trust
- •Availability of data to allow diagnosis of MetS (IDF criteria) collected at a screening visit
排除标准
- •Previous diagnosis of T2DM, CVD (stroke/cerebrovascular accident, transient ischaemic attack), peripheral arterial disease, or coronary heart disease (angina, myocardial infarction, coronary artery bypass surgery, angioplasty)
- •Life-limiting terminal illness
- •Pregnancy and/or breast feeding
- •Lack of capacity to give informed consent because of serious mental health problems or learning disability.
- •People who are housebound
- •Patients residing in nursing/care homes
- •Individuals who are unable to speak and understand English. (The intervention will be made appropriate for ethnically diverse populations, but individuals who are unable to understand, speak and read English will be excluded at this stage. However, if the self-management programme is found to be successful we would adapt it for non-English speakers.)
结局指标
主要结局
The proportion of people in the intervention and control groups with prevalent metabolic syndrome according to the IDF criteria.
时间窗: 12 months follow-up.
次要结局
- The prevalence of metabolic syndrome according to NCEP criteria(Compared at baseline versus 12 months, and for the intervention group versus the control group)
- Changes in depression/anxiety as measured by HADS(Compared at baseline versus 12 months, and for the intervention group versus the control group)
- Changes in individual components of the metabolic syndrome (fasting plasma glucose, triglycerides, HDL cholesterol, blood pressure, waist circumference), and 2 hour glucose(Compared at baseline versus 12 months, and for the intervention group versus the control group)
- Changes in biomarkers (hs-CRP, adiponectin, and insulin)(Compared at baseline versus 12 months, and for the intervention group versus the control group)
- Changes in physical activity as measured by IPAQ and pedometer(Compared at baseline versus 12 months, and for the intervention group versus the control group)
- Changes in general self-efficacy as measured by GSE(Compared at baseline versus 12 months, and for the intervention group versus the control group)
- Changes in dietary/nutritional intake measured by DINE(Compared at baseline versus 12 months, and for the intervention group versus the control group)
- Changes in Framingham risk score(Compared at baseline versus 12 months, and for the intervention group versus the control group)
- Changes in quality of life as measured by EuroQol EQ-5D(Compared at baseline versus 12 months, and for the intervention group versus the control group)